CHERP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.024600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.391200E-01
Normal-vs-Stage2
2.737000E-01
Normal-vs-Stage3
2.231400E-01
Normal-vs-Stage4
3.731800E-01
Stage1-vs-Stage2
6.189600E-01
Stage1-vs-Stage3
3.161400E-01
Stage1-vs-Stage4
5.321200E-01
Stage2-vs-Stage3
1.928380E-01
Stage2-vs-Stage4
3.639400E-01
Stage3-vs-Stage4
4.808800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.218600E-01
Normal-vs-AfricanAmerican
1.147630E-01
Normal-vs-Asian
6.058800E-01
Caucasian-vs-AfricanAmerican
3.687600E-01
Caucasian-vs-Asian
3.614200E-01
AfricanAmerican-vs-Asian
9.309900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.707000E-01
Normal-vs-Female
2.375200E-01
Male-vs-Female
5.844400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.074600E-01
Normal-vs-Age(41-60Yrs)
4.015600E-01
Normal-vs-Age(61-80Yrs)
2.470400E-01
Normal-vs-Age(81-100Yrs)
4.083800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.866000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.682770E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.446200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.617000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.689800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.757800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.327600E-01
Normal-vs-Daily Drinker
6.323400E-01
Normal-vs-Weekly Drinker
5.850800E-01
Normal-vs-Occasional Drinker
4.028600E-01
Normal-vs-Social Drinker
2.735400E-01
Non Drinker-vs-Daily Drinker
4.302200E-01
Non Drinker-vs-Weekly Drinker
2.442200E-01
Non Drinker-vs-Occasional Drinker
3.994200E-01
Non Drinker-vs-Social Drinker
7.220000E-01
Daily Drinker-vs-Weekly Drinker
8.568800E-01
Daily Drinker-vs-Occasional Drinker
8.914800E-01
Daily Drinker-vs-Social Drinker
6.276000E-01
Weekly Drinker-vs-Occasional Drinker
6.860800E-01
Weekly Drinker-vs-Social Drinker
4.259800E-01
Occasional Drinker-vs-Social Drinker
6.547800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.595400E-01
Normal-vs-Grade 2
6.081400E-01
Normal-vs-Grade 3
1.125810E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.428600E-01
Grade 1-vs-Grade 3
8.192400E-01
Grade 1-vs-Grade 4
2.595400E-01
Grade 2-vs-Grade 3
5.043200E-01
Grade 2-vs-Grade 4
6.081400E-01
Grade 3-vs-Grade 4
1.125810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.594960E-01
Normal-vs-NonDiabetic
4.396800E-01
Diabetic-vs-NonDiabetic
7.600400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.836000E-01
Normal-vs-NoPancreatitis
2.928400E-01
Pancreatitis-vs-NoPancreatitis
8.516600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.591200E-01
Normal-vs-N1
2.803800E-01
N0-vs-N1
7.497000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.938600E-01
Normal-vs-TP53-NonMutant
4.604000E-01
TP53-Mutant-vs-TP53-NonMutant
9.547000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
